Goodluck India Q1 FY27: Margin expansion, export momentum, and Defence begins to scale

Goodluck India Limited opened FY27 with a strong quarter on the consolidated basis. Total income rose 30.9% year on year to INR 1,292.22 crore, while EBITDA grew 45.8% to INR 139.66 crore and reported profit after tax increased 67.4% to INR 67.22 crore. The operating leverage was visible in margins. Consolidated EBITDA margin improved to 10.8% from 9.7% a year ago, while PAT margin improved to 5.2% from 4.1%.

The company attributed the improved profitability to a better product mix, high utilization, and operational efficiencies. Annualised capacity utilisation was stated at about 98% in Q1 FY27, indicating the base business is running near peak. Exports were another key driver. Export revenue grew around 53% year on year and contributed about 29% of quarterly revenue, up from 27% in FY26 and 25% in FY25.

Q1 FY27 in numbers

The quarter reflected growth across both scale and profitability. Sales volume increased 8.8% year on year to 1,22,718 MT. On the consolidated P and L, income from operations was INR 1,273.47 crore and total income was INR 1,292.22 crore. Costs increased broadly in line with the scale up, but EBITDA expanded faster than revenue.

Business mix and what it implies

In the investor presentation, Goodluck disclosed a Q1 FY27 segment mix by share: CR sheet and pipes at 31%, precision pipes and auto tubes at 26%, engineering structures and fabrication at 20%, forgings at 17%, and defence at 6%. While defence is still a small part of revenue mix, it became the most discussed segment on the earnings call because it carries meaningfully higher profitability.

Management also shared indicative EBITDA margin ranges for key lines. CR and pipes were described as a 3% to 5% EBITDA business, while precision tubes were stated at 12% to 13%. Solar structures were cited at about 7% to 8%, infrastructure structures at 10% to 11%, and forgings at 12% to 13%. Defence margins were guided higher, with management indicating a 30% to 35% EBITDA margin range, and citing Q1 defence revenue at about INR 80 crore with an EBITDA margin of about 38%.

This mix matters because Goodluck is increasingly trying to shift the portfolio toward value-added products such as precision tubes, hydraulic tubes, forgings, and engineering structures, while keeping the higher-volume legacy categories relevant for scale. The company said value-added products already represent about 60% of the mix and that future capacity addition is being targeted primarily at value-added lines.

Defence: certification, orders, and a delayed expansion

The defence subsidiary, Goodluck Defence and Aerospace Limited, received DGQA certification for prescribed technical, operational, and quality assurance requirements, specifically for 155mm M107 ready-to-fill artillery shells assembled with a recovery plug. The company highlighted it cleared visual examination, gauging, dimensional inspection and dynamic tests.

During the quarter and subsequent communications, management referenced orders totalling INR 255 crore plus INR 52 crore for 155mm shells in ready-to-fill condition. On the earnings call, management clarified the INR 255 crore order is approximately 50,000 shells to be executed over 10 months, and the INR 52 crore order is for 20,000 shells over 3 months. The management also stated that demand has largely converged toward 155mm ammunition globally.

A key change versus earlier expectations was the expansion timeline. The investor presentation describes a plan to add 2,50,000 shells per annum within about 12 to 15 months, taking installed capacity to 4,00,000 shells per annum. In the concall, management acknowledged a delay of about 6 to 9 months, citing financial closure and the dependency on approvals and regulatory systems. Management said it hopes expansion activity can start around Q4 FY27, and indicated commercialization may take about a year. They also noted that even with plant capacity of 4,00,000 shells, achievable capacity may be closer to 3,50,000 shells per annum at around 90% utilization.

This segment also dominated shareholder questions on capital allocation. Multiple investors challenged the decision to raise funds at the subsidiary level and the plan to list the subsidiary rather than pursuing a demerger or rights issue at the listed parent. Management responded that financial advisers preferred the current route, that the defence unit remains a subsidiary of Goodluck India, and that the feedback would be considered.

Exports, transmission structures, and value-added ramp-ups

Goodluck’s exports improved both in growth and in mix. Management attributed export growth to demand from the U.S. and Europe. The company also disclosed a specific export win: an order for about 14,500 MT of transmission line structures valued at USD 13.6 million from an international entity.

In value-added tubes, the company’s hydraulic tubes plant, inaugurated in 2025 with 50,000 MTPA capacity and positioned as an import substitution opportunity for seamless tubes, is ramping up. Management said hydraulic tube utilisation improved to around 60% to 65% in Q1 FY27, from around 50% earlier.

On costs and margins, management acknowledged risks from volatile logistics and petroleum-linked inputs, especially with ongoing geopolitical uncertainty. They also stated it is difficult to predict whether input cost relief, if it comes, will translate into sustained margin expansion or be passed through to customers.

Takeaways for investors

Goodluck’s Q1 FY27 results show a company benefiting from operating leverage, export momentum, and a mix shift. Consolidated margins crossed the 10% EBITDA threshold, and the defence vertical is moving from capability build-out to meaningful revenues, supported by certification and confirmed orders.

At the same time, the narrative will remain sensitive to execution. The defence expansion is now delayed by 6 to 9 months, and management repeatedly highlighted the dependency on approvals. Shareholder concerns on how value from the defence subsidiary will accrue to the listed parent were raised clearly on the call. FY27 will likely be judged on two things: the pace of execution in defence and value-added products, and whether the capital allocation framework becomes clearer as the subsidiary’s funding and listing plans progress.